| 24/06/26 | 15:21:21 | 24 Jun 2026 | | Posting of Annual Report and Notice of AGM |
| 24/06/26 | 07:00:03 | 24 Jun 2026 | | Acquisition and £2.75 million Fundraise |
| 23/06/26 | 17:04:06 | 23 Jun 2026 | | Final Results |
| 09/06/26 | 07:00:05 | 9 Jun 2026 | | New article: RNA medicine enters its second act |
| 02/06/26 | 08:57:26 | 2 Jun 2026 | | CEO Interview |
| 13/05/26 | 11:12:34 | 13 May 2026 | | CEO Interview: Thalia’s RNA Therapeutics Strategy |
| 20/04/26 | 07:00:04 | 20 Apr 2026 | | Change of Registered Address |
| 17/03/26 | 12:14:38 | 17 Mar 2026 | | Result of General Meeting and Change of Name |
| 27/02/26 | 07:00:13 | 27 Feb 2026 | | Notice of GM and Proposed Change of Name |
| 24/02/26 | 07:00:08 | 24 Feb 2026 | | CEO Appointment & Name Change Thalia Therapeutics |
| 17/12/25 | 07:00:03 | 17 Dec 2025 | | Business and Operational Update |
| 25/09/25 | 07:00:03 | 25 Sept 2025 | | Interim Results |
| 23/09/25 | 07:00:04 | 23 Sept 2025 | | Partnership with University of Strathclyde’s CMAC |
| 22/09/25 | 07:00:04 | 22 Sept 2025 | | N4 Pharma’s Nuvec® Targets Lung Cancer Cells |
| 19/09/25 | 07:00:16 | 19 Sept 2025 | | Notice of Results, Analyst & Investor Presentation |
| 11/09/25 | 07:00:17 | 11 Sept 2025 | | Investor Event and Presentation |
| 30/07/25 | 13:55:43 | 30 Jul 2025 | | Article on Nuvec®’s Potential in RNA Therapeutics |
| 14/07/25 | 07:00:14 | 14 Jul 2025 | | Investor Webinar |
| 08/07/25 | 07:00:09 | 8 Jul 2025 | | Directorate Change |
| 30/06/25 | 14:15:22 | 30 Jun 2025 | | Result of AGM |
| 30/06/25 | 07:00:09 | 30 Jun 2025 | | AGM Statement |
| 25/06/25 | 07:00:11 | 25 Jun 2025 | | Insight Event for Retail Investors |
| 06/06/25 | 07:00:07 | 6 Jun 2025 | | Final Results, Annual Report and Notice of AGM |
| 27/05/25 | 07:00:15 | 27 May 2025 | | Establishment of New Senior Leadership Team |
| 23/05/25 | 12:37:31 | 23 May 2025 | | TR-1: Notification of major holdings |
| 21/05/25 | 16:11:58 | 21 May 2025 | | Holding(s) in Company |
| 15/05/25 | 15:13:18 | 15 May 2025 | | Change of Registered Address |
| 12/05/25 | 07:00:03 | 12 May 2025 | | N4 101 In Vivo Study Results |
| 09/05/25 | 08:24:55 | 9 May 2025 | | Holding(s) in Company |
| 29/04/25 | 16:25:23 | 29 Apr 2025 | | Holding(s) in Company |
| 29/04/25 | 11:05:49 | 29 Apr 2025 | | Holding(s) in Company |
| 28/04/25 | 14:30:57 | 28 Apr 2025 | | Holding(s) in Company |
| 23/04/25 | 14:32:11 | 23 Apr 2025 | | TR-1: Standard form notification of major holdings |
| 22/04/25 | 11:56:34 | 22 Apr 2025 | | Result of General Meeting |
| 04/04/25 | 07:08:13 | 4 Apr 2025 | | Posting of Circular and Notice of General Meeting |
| 01/04/25 | 16:08:02 | 1 Apr 2025 | | Placing and Subscription to raise £1,750,000 |
| 18/02/25 | 12:34:43 | 18 Feb 2025 | | Holding(s) in Company |
| 07/02/25 | 07:00:07 | 7 Feb 2025 | | Investor Webinar |
| 27/01/25 | 07:00:08 | 27 Jan 2025 | | Investor Webinar |
| 16/01/25 | 07:00:08 | 16 Jan 2025 | | N4 Pharma Non-Executive Director Q&A |
| 08/01/25 | 07:00:05 | 8 Jan 2025 | | Directorate Changes |
| 12/12/24 | 07:00:04 | 12 Dec 2024 | | N4 101 In Vitro Results |
| 04/12/24 | 07:00:03 | 4 Dec 2024 | | New Patent Filing |
| 28/11/24 | 07:00:09 | 28 Nov 2024 | | Grant of Options |
| 01/11/24 | 07:00:09 | 1 Nov 2024 | | N4 Pharma CEO Q&A Now LIVE |
| 24/10/24 | 07:00:09 | 24 Oct 2024 | | New Corporate Presentation |
| 24/09/24 | 07:00:07 | 24 Sept 2024 | | Interim Results |
| 17/09/24 | 08:04:08 | 17 Sept 2024 | | SRI Research Update |
| 09/09/24 | 07:00:08 | 9 Sept 2024 | | Director Appointment |
| 23/08/24 | 08:30:00 | 23 Aug 2024 | | Change of Auditor |
